Skip to main content

Table 2 Comparison of Th cytokine concentrations in the different groups

From: Th cytokine profile in childhood-onset systemic lupus erythematosus

Cytokine

cSLE (n = 33)

Active cSLE (n = 17)

Inactive cSLE (n = 16)

Control (n = 30)

Pad

Pbd

Pcd

Pbc

IL-2

53.11 (27.80–96.71)

89.99 (59.49–178.10)

28.80 (21.64–39.34)

32.51 (16.90–53.39)

0.047*

0.012*

0.395

0.003**

IL-4

31.73 (12.20–76.14)

14.17 (10.88–45.61)

51.08 (15.40–126.39)

41.28 (31.39–80.06)

0.565

0.143

0.806

0.162

IL-5

5.91 (4.36–11.89)

8.24 (4.92–13.91)

5.07 (4.54–9.34)

6.47 (4.83–9.53)

0.802

0.537

0.783

0.619

IL-6

41.80 (19.03–126.67)

41.80 (18.73–87.16)

70.02 (17.72–139.57)

36.00 (18.63–61.98)

0.245

0.438

0.302

0.490

IL-9

43.24 (23.52–64.37)

46.23 (18.00–112.15)

43.24 (26.45–62.75)

35.82 (16.38–76.85)

0.438

0.482

0.912

0.452

IL-10

11.54 (4.80–29.82)

13.30 (9.98–33.67)

5.94 (2.97–16.25)

5.71 (2.91–9.03)

0.001**

0.001**

0.162

0.039*

IL-13

18.29 (8.57–47.65)

18.20 (7.30–40.57)

18.76 (8.81–56.03)

26.81 (16.22–46.22)

0.253

0.138

0.739

0.423

IL-17A

38.90 (12.18–453.90)

94.56 (24.29–450.40)

16.25 (11.55–458.13)

45.42 (17.92–79.22)

0.291

0.522

0.483

0.937

IL-17F

17.30 (5.37–22.44)

11.34 (4.95–21.34)

20.52 (12.12–59.75)

19.19 (9.95–44.56)

0.366

0.235

0.906

0.249

IL-21

65.33 (29.17–176.17)

55.07 (27.55–183.42)

87.18 (29.17–137.60)

18.01 (10.51–39.17)

0.003**

0.047*

0.044*

0.807

IL-22

24.11 (13.35–63.48)

21.43 (10.02–26.28)

37.34 (16.43–132.33)

63.85 (30.84–133.13)

0.217

< 0.001**

0.972

0.086

IFN-γ

72.95 (16.59–227.02)

58.80 (18.17–336.42)

72.95 (8.96–205.93)

69.61 (30.04–148.88)

0.555

0.524

0.883

0.652

TNF-α

46.95 (21.35–114.53)

108 (25.29–131.23)

25.03 (13.48–77.26)

17.50 (11.68–30.65)

0.151

0.150

0.297

0.877

  1. IL-2 Interleukin-2, IL-4 Interleukin-4, IL-5 Interleukin-5, IL-6 Interleukin-6, IL-9 Interleukin-9, IL-10 Interleukin-10, IL-13 Interleukin-13, IL-17A Interleukin-17A, IL-17F Interleukin-17F, IL-21 Interleukin-21, IL-22 Interleukin-22, IFN-γ Interferon-γ, TNF-a Tumour necrosis factor-α, Pad the cSLE group compared with the control group, Pbd the active cSLE group compared with the control group, Pcd the inactive cSLE group compared with the control group, Pbc the active cSLE group compared with the inactive cSLE group; *P < 0.05, **P < 0.01